Skip to main content
SpringerLink
Log in

Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism (Italy)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective: Insulin resistance and increased levels of serum steroids have been hypothesized to be relevant etiological factors for breast cancer. Measurements of markers of insulin resistance and elevated serum steroids may identify women at high risk for breast cancer. The present study analyzed the association of breast cancer with markers of insulin resistance and elevated serum sex steroids, abdominal adiposity, increase in sebum production and hirsutism in a case–control study nested in a prospective cohort study.

Methods: Between 1987 and 1992, 10,786 women (aged 35–69) were recruited in a prospective study on breast cancer in Italy, the ORDET study. Women with a history of cancer and on hormone therapy were excluded at baseline. At recruitment, abdominal adiposity was calculated from the ratio of waist-to-hip circumferences. Sebum production was measured on the forehead under standardized conditions using a sebumeter. Nine androgen-sensitive body areas were evaluated for hirsutism and a total hirsutism score was computed. After an average of 5.5 years of follow-up, 144 breast cancer cases were identified among the participants of the cohort. For each breast cancer case, four matched controls were randomly chosen from members of the cohort who did not develop breast cancer during the follow-up period.

Results: Waist-to-hip ratio was associated with breast cancer in premenopausal women: age and body mass index (BMI) adjusted relative risk (RR) for the highest tertile of waist-to-hip ratio was 2.2 [95% confidence interval (CI) 1.04–4.75], p for trend 0.03. In the analysis conducted within strata of BMI, the effect of waist-to-hip ratio was confined to the group of thinner women: RR for the highest tertile of waist-to-hip ratio was 3.4 (95% CI 1.2–9.5). Sebum production and hirsutism were associated with breast cancer among postmenopausal women. Age and BMI adjusted RRs for the upper tertiles were 2.2 (95% CI 1.1–4.6), p for trend 0.01, and 2.3 (95% CI 1.1–4.9), p for trend 0.03, for sebum and hirsutism, respectively.

Conclusion: These results add evidence for a role of hormones and metabolic alterations in breast cancer etiology and for different relations of these risk factors with breast cancer in premenopausal and postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zumo. B (1994) Hormonal profiles in women with breast cancer. Obstet Gynecol Clin N Am 21: 751–772.

    Google Scholar 

  2. Kazer RR (1995) Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer 62: 403–406.

    Google Scholar 

  3. Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7: 605–625.

    Google Scholar 

  4. Papa V, Belfiore A (1996) Insulin receptor in human breast cancer: biological and clinical role. J Endocrinol Invest 9: 324–333.

    Google Scholar 

  5. Osborne CK, Clemmons DR, Arteaga CI (1997) Regulation of breast cancer growth by insulin-like growth factors. J Steroid Biochem Mol Biol 37: 805–809.

    Google Scholar 

  6. Cullen KJ, Yee D, Sly WS, et al. (1990) Insulin like growth factor receptor expression and function in human breast cancer. Cancer Res 50: 48–53.

    Google Scholar 

  7. Bruning PF, Bonfer JMG, van Nooryrd PAH, Hart AAM, De Jong-Bakker M, Noojien WJ (1992) Insulin resistance and breast cancer risk. Int J Cancer 52: 511–516.

    Google Scholar 

  8. Del Giudice ME, Fantus IG, McKeown-Eyssen G, Page D, Goodwin PJ (1998) Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111–120.

    Google Scholar 

  9. Lippman M, Bolan G, Huff K (1976) The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4610–4618.

    Google Scholar 

  10. Andreson JN, Peck EJ, Clark JH (1975) Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei. Endocrinology 96: 160–167.

    Google Scholar 

  11. Fishman J, Martucci C (1978) Differential biological activity of estradiol metabolites. Pediatrics 62: 1128–1133.

    Google Scholar 

  12. Rudali G, Apiou F, Muel B (1975) Mammary cancer produced in mice with estriol. Eur J Cancer 11: 39–41.

    Google Scholar 

  13. Berrino F, Muti P, Micheli A, et al. (1996) Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88: 291–296.

    Google Scholar 

  14. Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW (1990) Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 50: 3859–3862.

    Google Scholar 

  15. Dorgan JF, Longcope C, Stephenson HE, et al. (1996) Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 533–539.

    Google Scholar 

  16. Hankinson SE, Willett WC, Manson JE, et al. (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90: 1292–1299.

    Google Scholar 

  17. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GWA (1994) Prospective study on endogenous hormones and breast cancer. Cancer Detect Prev 18: 79–85.

    Google Scholar 

  18. Cauley J, Lucas FL, Kuller L, Stone K, Browner W, Cummings SR (1999) Elevated serum estradiol and testosterone concentrations are associated with high risk for breast cancer. Ann Intern Med 130: 270–277.

    Google Scholar 

  19. Toniolo P, Levitz M, Zeleniuch-Jacquotte A, et al. (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87: 190–197.

    Google Scholar 

  20. Thomas HV, Key TJ, Allen DS, et al. (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women. Br J Cancer 76: 401–405.

    Google Scholar 

  21. Zeleniuchjacquotte A, Bruning PF, Bonfrer JMG, et al. (1997) Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 145: 1030–1038.

    Google Scholar 

  22. Barbieri RL, Smith S, Ryan KJ (1988) The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 50: 197–212.

    Google Scholar 

  23. Kissebah A, Peiris A, Evans D (1988) Mechanisms associating body fat distribution to glucose tolerance and diabetes mellitus: window with a view. Acta Med Scand 723 (Suppl.): 79–89.

    Google Scholar 

  24. Peiris AN, Sothmann MS, Hennes MI, et al. (1989) Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women. Am J Clin Nutr 49: 758–764.

    Google Scholar 

  25. Schiavone FE, Rietschel RL, Sgoutas D, Harris R (1983) Elevated free testosterone levels in women with acne. Dermatology 119: 799–802.

    Google Scholar 

  26. Mattsson LA, Cullberg G, Hamberger L, Samsioe G, Silferstolpe G (1984) Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil Steril 42: 579–584.

    Google Scholar 

  27. Jung-Hoffmann C, Taubert HG, Kuhl H (1987) Direct radioimmunoassay of free testosterone in the evaluation of androgenetic manifestations in women. Gynecol Endocrinol 1: 83–92.

    Google Scholar 

  28. Reingold SB, Rosenfield RL (1987) The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol 123: 209–212.

    Google Scholar 

  29. Rosenfield RL, Lucky AW (1993) Clinical expressions of androgen excess. Endocrinol Metab Clin N Am 22: 507–532.

    Google Scholar 

  30. Lucky AW (1995) Hormonal correlates of acne and hirsutism. Am J Med 98(Suppl. IA): 89S–94S.

    Google Scholar 

  31. Wu CH (1979) Estrogen-androgen balance in hirsutism. Fertil Steril 32: 269–275.

    Google Scholar 

  32. Zlotogorski A, Glaser B, Bercovici B, Dikstein S (1991) Sebum measurements for rapid identification of hyperandrogenism due to ovarian Leydig cell tumor. Int J Dermatol 30: 276–277.

    Google Scholar 

  33. Achard C, Thiers J (1921) Le viritisme pilaire et son association a l'insufficiance glycolytique. Bull Acad Natl Med (Paris) 86: 51–55.

    Google Scholar 

  34. Björntorp P (1993) Androgens, the metabolic syndrome, and non-insulin-dependent diabetes mellitus. Ann NY Acad Sci 676: 242–252.

    Google Scholar 

  35. Kissebah A, Peiris A, Evans D (1988) Mechanisms associating body fat distribution to glucose tolerance and diabetes mellitus: window with a view. Acta Med Scand 723: 79–89.

    Google Scholar 

  36. De Fronzo RA, Jacot E, Jequier E, Maeden E, Wahren J, Felber P (1981) The effect of insulin on the disposal of intravenous glucose; results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000–1007.

    Google Scholar 

  37. Krotkiewski M, Björntorp P (1986) Muscle tissue in obesity with different distribution of adipose tissue, effect of physical training. Int J Obes 10: 331–341.

    Google Scholar 

  38. Lillioja S, Young AA, Culter CL (1987) Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80: 415–424.

    Google Scholar 

  39. Hom FG, Goodner CJ (1984) Insulin dose-response characteristics among individual muscle and adipose tissues measured in the rat in vivo with 3(H)2-deoxyglucose. Diabetes 33: 153–159.

    Google Scholar 

  40. Wallberg-Henriksson H (1987) Glucose transport into skeletal muscle. Influence of contractile activity, insulin, catecholamines on diabetes mellitus. Acta Physiol Scand (Suppl.) 564: 1–80.

    Google Scholar 

  41. Bonen A, Tan MH, Watson-Wright WM (1981) Insulin binding and glucose uptake in rodent skeletal muscle. Diabetes 30: 702–704.

    Google Scholar 

  42. Bolinder J, Kager L, Östman J, Arner P (1983) Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32: 117–129.

    Google Scholar 

  43. Bolinder J, Engfeldt P, Östman J, Arner P (1983) Site differences in insulin receptor binding and insulin action in subcutaneous fat of obese females. J Clin Endocrinol 57: 455–471.

    Google Scholar 

  44. Ferrarrini E, Barrett EJ, Bevilacquas S, DeFronzo RA (1983) Effects of fatty acid on glucose production and utilization in man. J Clin Invest 72: 1737–1744.

    Google Scholar 

  45. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 2: 785–789.

    Google Scholar 

  46. Berrino F, Pisani P, Muti P, et al. (1988) Prospective study of hormones and diet in the actiology of breast cancer. In: Riboli E, Saracci R, eds. Diet, Hormones, and Cancer: Methodological Issues for Prospective Studies. Lyon: International Agency for Research on Cancer, Technical Report No. 4, pp. 34–38.

    Google Scholar 

  47. Ferrimen D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 24: 1440–1447.

    Google Scholar 

  48. Maroulis GB (1981) Evaluation of hirsutism and hyperandrogenernia. Fertil Steril 36: 273–305.

    Google Scholar 

  49. Muti P, Trevisan M, Panico S, et al. (1996) Body fat distribution, peripheral indicators of androgenic activity, and blood pressure in women. Ann Epidemiol 6: 181–187.

    Google Scholar 

  50. Waterhouse J, Muir C, Shanmugaratnam K, eds (1982) Cancer Incidence in Five Continents, Vol. IV. Lyon, France: IARC Scientific Publications.

    Google Scholar 

  51. Parlin DM, Whelan J, Ferlay L, Raymond L, Young J, eds (1997) Cancer Incidence in Five Continents, Vol. VII. Lyon, France: IARC Scientific Publications.

    Google Scholar 

  52. Kleinbaum DG, Kupper LL, Morgenstern H (1986) Measures of association. In: Kleinbaum DG, Kupper LL, Morgenstern H, eds. Epidemiologic Research. New York: Van Nostrand Reinhold, pp. 146–147.

    Google Scholar 

  53. Fleiss JL (1986) Reliability of measurement. In: Fleiss JL, ed. The Design and Analysis of Clinical Experiments. New York: John Wiley & Sons, pp. 1–14.

    Google Scholar 

  54. De Waard F (1975) Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35: 3351–3356.

    Google Scholar 

  55. Swanson CA, Brinton LA, Taylor PR, Licitra LM, Ziegler RG, Schairer C (1989) Body size and breast cancer risk assessed in women participating in the Breast Cancer Detection Demonstration Project. Am J Epidemiol 130: 1133–1141.

    Google Scholar 

  56. London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE (1989) Prospective study of relative weight, height, and risk of breast cancer. JAMA 262: 2853–2858.

    Google Scholar 

  57. Bruning PF, Bonfrer JM, Hart AA, et al. (1992) Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 52: 511–516.

    Google Scholar 

  58. Mannisto S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M (1996) Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 68: 8–13.

    Google Scholar 

  59. Eng-Hen N, Gao F, Chen-Yang J, Gay-Hui H, Khee-Chee S (1997) Risk factors for breast cancer in Singaporean Chinese women. The role of obesity. Cancer 80: 725–731.

    Google Scholar 

  60. Schapiro DV, Kumar NB, Lyman GH, Cox CE (1990) Abdominal obesity and breast cancer risk. Ann Intern Med 112: 182–186.

    Google Scholar 

  61. Huang Z, Willett WC, Colditz GA, et al. (1999) Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 150: 1316–1324.

    Google Scholar 

  62. Franceschi S, Favero A, La Vecchia C, et al. (1996) Body size indices and breast cancer risk before and after menopause. Int J Cancer 67: 181–186.

    Google Scholar 

  63. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB (1990) Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 131: 794–803.

    Google Scholar 

  64. Ballard-Barbash R, Schatzkin A, Carter CL, Kannel WB, Kreger BE, D'Agostino RB (1990) Body fat distribution and breast cancer in the Framingham study. J Natl Cancer Inst 82: 286–290.

    Google Scholar 

  65. Kaaks R, Van Noord PA, Den Tonkelaar I, Peeters PJH, Riboli E, Grobbee DE (1998) Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch “DOM” cohort. Int J Cancer 76: 647–651.

    Google Scholar 

  66. Potter JD, Cerhan JR, Sellers TA, et al. (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 4: 319–326.

    Google Scholar 

  67. Key TJA, Pike MC (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29–43.

    Google Scholar 

  68. Potischman N, Swanson C, Siiteri P, Hoover N (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88: 756–758.

    Google Scholar 

  69. Stoll BA (1996) Obesity and breast cancer. Int J Obesity 20: 389–392.

    Google Scholar 

  70. Pérusse L, Deprés JP, Lemieux S, Rice T, Rao DC, Bouchard C (1996) Familial aggregation of abdominal visceral fat level: results from the Quebec family study. Metabolism 45: 378–382.

    Google Scholar 

  71. Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo P (1994) Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of menstrual cycle. Am J Epidemiol 140: 518–525.

    Google Scholar 

  72. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 75: 1075–1079.

    Google Scholar 

  73. Muti P, Trevisan M, Micheli A, et al. (1996) Reliability of serum hormones in premenopausal and postmenopausal women during a one-year period. Cancer Epidemiol Biomarkers Prev 5: 917–922.

    Google Scholar 

  74. Schapira DV, Clark RA, Wolff PA, Jarrett AR, Kumar NB, Aziz NM (1994) Visceral obesity and breast cancer risk. Cancer 74: 632–639.

    Google Scholar 

  75. Cara JF, Rosenfield RL (1988) Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 123: 733–739.

    Google Scholar 

  76. Hernandez ER, Resnick CE, Holtzclaw D, Payne DW, Adashi EY (1988) Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular and pharmacological hormonal actions. Endocrinology 122: 2034–2043.

    Google Scholar 

  77. Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22: 1000–1009.

    Google Scholar 

  78. Toscano V, Balducci R, Bianchi P, et al. (1993) Two different pathogenetic mechanisms may play a role in acne and hirsutism Clin Endocrinol 39: 551–556.

    Google Scholar 

  79. Hay JB, Hodgins MB (1974) Metabolism of androgens by human skin in acne. Br J Dermatol 91: 123–133.

    Google Scholar 

  80. Kutten F, Mowszowicz I, Schaison G, Mauvais-Jarvis P (1977) Androgen production and skin metabolism in hirsutism. J Endocrinol 75: 83–91.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy

    Paola Muti, Andrea Micheli, Vittorio Krogh & Franco Berrino

  2. Department of Social and Preventive Medicine, State University of New York at Buffalo, Buffalo, NY, 14214, USA

    Paola Muti, Jo L. Freudenheim, Jun Yang, Holger J. Schünemann & Maurizio Trevisan

  3. Department of Pediatric Hematology and Oncology, Medical School of Hannover, Hannover, Germany

    Martin Stanulla & Holger J. Schünemann

Authors
  1. Paola Muti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Stanulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Micheli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vittorio Krogh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jo L. Freudenheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Holger J. Schünemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Maurizio Trevisan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Franco Berrino
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muti, P., Stanulla, M., Micheli, A. et al. Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism (Italy). Cancer Causes Control 11, 721–730 (2000). https://doi.org/10.1023/A:1008966623901

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008966623901

Search

Navigation